Whereas NF-B has potent antiapoptotic function in most cell types, it was reported that in pancreatic ␤ cells it serves a proapoptotic function and may contribute to the pathogenesis of autoimmune type 1 diabetes. To investigate the role of ␤ cell NF-B in autoimmune diabetes, we produced transgenic mice expressing a nondegradable form of IB␣ in pancreatic ␤ cells (RIP-mIB␣ mice). ␤ cells of these mice were more susceptible to killing by TNF-␣ plus IFN-␥ but more resistant to IL-1␤ plus IFN-␥ than normal ␤ cells. Similar results were obtained with ␤ cells lacking IB kinase ␤, a protein kinase required for NF-B activation. Inhibition of ␤ cell NF-B accelerated the development of autoimmune diabetes in nonobese diabetic mice but had no effect on glucose tolerance or serum insulin in C57BL/6 mice, precluding a nonphysiological effect of transgene expression. Development of diabetes after transfer of diabetogenic CD4 ؉ T cells was accelerated in RIP-mIB␣/nonobese diabetic mice and was abrogated by anti-TNF therapy. These results suggest that under conditions that resemble autoimmune type 1 diabetes, the dominant effect of NF-B is prevention of TNF-induced apoptosis. This differs from the proapoptotic function of NF-B in IL-1␤-stimulated ␤ cells.
A poptosis of pancreatic ␤ cells is a critical component in the pathogenesis of autoimmune type 1 diabetes (T1D) (1, 2) , but the relevant death effector(s) and inhibitor(s) that function in these cells are not well established. Perforin mediates contact-dependent ␤ cell death by CD8 ϩ T cells (3) but does not explain ␤ cell killing by CD4 ϩ T cells, the dominant death effector cells in nonobese diabetic (NOD) mice that develop T1D (4, 5) . Fas ligand was proposed to have a crucial role in ␤ cell apoptosis in these mice (6, 7) , but more recent evidence argues against a dominant role for Fas ligand (8, 9) . Besides contact-dependent cytotoxicity, CD4 ϩ T cells induce target cell death via soluble mediators such as TNF-␣, IL-1, and IFN-␥. Recently, TNF-␣ or TNF-␣ plus IFN-␥ were suggested to be critical death mediators in the final effector phase of ␤ cell destruction in T1D (10) (11) (12) . However, IL-1␤ and nitric oxide (NO) were also implicated in ␤ cell death (13) (14) (15) .
The role of transcription factor NF-B, whose activity is stimulated by both TNF-␣ and IL-1 (16) in the pathogenesis of T1D, has been controversial. Most reports have described a proapoptotic role for NF-B in pancreatic ␤ cell death (17) (18) (19) (20) (21) . These findings are in stark contrast to the well established antiapoptotic function of NF-B in most other cell types (22) (23) (24) (25) . The difference could be due to a peculiarity of pancreatic ␤ cells but also may reflect the involvement of different death effectors and NF-B activators. With respect to the latter, it is well established that NF-B activation by TNF family members serves an antiapoptotic function and that NF-B activity is essential for prevention of TNF-␣-induced death (22) (23) (24) (25) . However, NF-B activation was suggested to have proapoptotic effects after activation by IL-1, UV light, or chemotherapeutic agents (26) , where it mediates the synthesis of Fas ligand (27) and, possibly, other death mediators (28) . We previously found an antiapoptotic role for NF-B in murine insulinoma cells (29) , but these results are contradicted by the proapoptotic role of NF-B in cultured primary islet cells or rat insulinoma cells (17) (18) (19) (20) (21) . However, the conditions used in all of these studies are likely to be very different from those affecting ␤ cells in vivo during the pathogenesis of autoimmune T1D. Thus, it is still unknown whether NF-B in ␤ cells contributes to or inhibits ␤ cell destruction and the development of T1D. This is an important issue relevant to development of antidiabetic agents that modulate NF-B activity. Furthermore, recent results show that inhibition of NF-B in inflammatory cells and hepatocytes attenuates the development of obesity-induced insulin resistance and type 2 diabetes (T2D) (30, 31) . However, because ␤ cell destruction may also contribute to the pathogenesis of advanced T2D, it is important to elucidate the long-term effect of NF-B inhibition on ␤ cell survival before development of antidiabetic agents that target this pathway.
To address these issues, we examined the in vivo function of ␤ cell NF-B in a mouse model for autoimmune T1D. Our results indicate that the antiapoptotic role of NF-B in ␤ cells exposed to TNF-␣ outweighs its potential proapoptotic role. Hence, inhibition of NF-B activation in ␤ cells accelerated the development of T1D in NOD mice.
Results
Transgenic Mice Expressing IB␣ ''Superrepressor'' in ␤ Cells. To explore the in vivo function of NF-B in T1D, we produced transgenic NOD mice expressing a degradation-resistant form of IB␣ (mIB␣) known as the superrepressor, which functions as a selective and potent NF-B inhibitor (32) , in pancreatic ␤ cells (RIP-mIB␣/NOD mice). This was done by direct injection of transgene DNA into NOD mouse eggs [supporting information (SI) Fig. 7A ]. Immunoblot analysis showed efficient mIB␣ expression in pancreatic islets (SI Fig. 7B ). RIP-mIB␣/NOD-SCID mice and RIP-mIB␣/C57BL/6 mice without insulitis were produced by backcrossing RIP-mIB␣/NOD mice to NOD-SCID and C57BL/6 mice for two and eight generations, respectively. All these strains showed apparently normal islet architecture and distribution of ␤ cells, ␣ cells, and ␦ cells (SI Fig. 7 C and D) .
We next investigated the functionality of mIB␣. Immunoblotting demonstrated that mIB␣ indeed was not degraded after TNF-␣ treatment of pancreatic islet cells from transgenic mice, whereas endogenous IB␣ in transgenic or nontransgenic islets was degraded (Fig. 1A) . Furthermore, triple-color confocal microscopy demonstrated that nuclear translocation of the RelA/p65 NF-B subunit in response to TNF-␣ was impaired selectively in insulin-positive ␤ cells but remained intact in a small number of insulin-negative non-␤ cells within mIB␣-islet cells (Fig. 1B) . In mIB␣-transgenic islets, only 9 of among 218 insulin-positive ␤ cells showed nuclear translocation of RelA/p65 after TNF-␣ treatment (4.1%). In contrast, TNF-␣ treatment of nontransgenic islets induced nuclear translocation of RelA/p65 in almost all islet cells: 177 of among 178 insulinpositive ␤ cells showed nuclear translocation of RelA/p65 after TNF-␣ treatment (99.4%) (Fig. 1B) .
Elevated Susceptibility of mIB␣-Transgenic Islets to TNF-␣-Induced
Death. Next, we investigated whether because of inhibition of NF-B, mIB␣-islet cells show altered sensitivity to proapoptotic stimuli. To avoid interference by preexisting insulitis, we isolated islets from RIP-mIB␣/C57BL/6 mice. When mIB␣-islet cells or nontransgenic counterparts were treated with 2-40 ng/ml TNF-␣ for 5 days, no appreciable cell death was noted by using the MTT assay that measures cell viabilities (data not shown). However, when the duration of TNF-␣ treatment was increased to Ͼ8 days, many islet cells did die. Hence, we titrated the dose and duration of cytokine treatment. When this was done, mIB␣-islet cells appeared more susceptible to treatment with 10-40 ng/ml TNF-␣ for 9 days compared with nontransgenic counterparts; however, in more than four independent experiments, the difference was statistically insignificant because of large interassay variance (P Ͼ 0.1) (Fig. 2A) . We next combined TNF-␣ with IFN-␥ because this cytokine combination was implicated in ␤ cell death in NOD mice (12, 33) . In four independent experiments, mIB␣-islet cells exhibited a significantly elevated death response relative to normal counterparts when incubated with 2 ng/ml TNF-␣ plus 100 units/ml IFN-␥ (T2F) for 9 days (P ϭ 0.02) (Fig. 2 A) . However, no significant difference (P Ͼ 0.1) in cell death was found between mIB␣-and nontransgenic islets after 9 days with 10 ng/ml TNF-␣ plus 100 units/ml IFN-␥ (T10F) because this treatment was also lethal to nontransgenic islet cells. Hoechst33342 staining also demonstrated a significantly increased apoptosis of mIB␣-islet cells after 9 days of T2F treatment compared with nontransgenic islet cells (P ϭ 0.02), confirming the results of the MTT assay (Fig.  2B) . To demonstrate that the cells that died after T2F treatment were insulin-producing ␤ cells, we conducted Hoechst33342 staining coupled with insulin immunocytochemistry. Fluorescent microscopy revealed that most of the apoptotic cells (Ͼ90%) showing typical nuclear condensation and/or fragmentation were insulinpositive ␤ cells (Fig. 2C) . The percentage of apoptotic cells with nuclear condensation and/or fragmentation amongst insulinpositive ␤ cells after T2F treatment was also significantly higher in cultures of mIB␣-islet cells than in nontransgenic islet cell cultures (P ϭ 0.00002) (Fig. 2D) . Immunofluorescent microscopy also showed that Ͼ90% of the cells cultured for 9 days without T2F treatment were insulin-positive, thus contamination with other cell types such as fibroblasts was quite low (data not shown).
We next studied susceptibility of mIB␣-islet cells to IL-1␤ because IL-1␤-induced NF-B activation was reported to be detrimental to islet cells (15, 18) . IL-1␤ alone did not induce noticeable death of transgenic or nontransgenic primary islet cells (data not (C and D) mIB␣-islet cells were treated as in B. They were stained with insulin Ab together with Hoechst33342 and examined by fluorescent microscopy ( * , P ϭ 0.00002; total cell numbers observed were 247 and 199, respectively). (E) mIB␣-islet cells were incubated with 5 ng/ml IL-1␤ plus 100 units/ml IFN-␥ (I5F) for 5 days, and cell viability was assessed by the MTT assay ( * , P ϭ 0.02; means Ϯ SE from six independent experiments performed in triplicate). (F) Tgϩ and TgϪ islet cells were subjected to I5F treatment for 48 h. Cell lysates were immunoblotted for iNOS expression.
shown). However, treatment with IL-1␤ (5 ng/ml) plus IFN-␥ (100 units/ml) (I5F) for 5 days resulted in considerable death of nontransgenic islet cells, and by comparison, fewer mIB␣-islet cells died after I5F treatment (P ϭ 0.02) (Fig. 2E ). Primary islet cell death by I5F was of apoptotic morphology, characterized by nuclear condensation/fragmentation seen after Hoechst33342 staining (data not shown). Induction of inducible NO synthase (iNOS), encoded by an NF-B target gene, by I5F was remarkably compromised in mIB␣-islets (Fig. 2F ). Because NO was proposed to function as a death mediator (13, 15) , these results provide potential explanation to the elevated resistance of mIB␣-islet cells to I5F treatment.
To further corroborate these ex vivo findings, we produced mice with ␤ cell-specific deletion of Ikk␤, the gene coding for a catalytic subunit of the IKK complex that is required for IB␣ phosphorylation and NF-B activation (16) (Ikk␤ ⌬␤ cell mice), by breeding Ikk␤ F/F mice (34) with RIP-Cre mice, which specifically express Cre recombinase in ␤ cells (35) . PCR analysis of genomic DNA indicated nearly complete recombination in pancreatic islets of Ikk␤ ⌬␤ cell mice but not in other major organs or in pancreatic islets of control Ikk␤ F/F mice (Fig. 3A) . Islet cells from Ikk␤ ⌬␤ cell mice appeared more susceptible to killing by incubation with 10-40 ng/ml TNF-␣ for 9 days compared with Ikk␤ F/F islet cells; however, the difference was statistically insignificant (P Ͼ 0.1) (Fig. 3B) , similar to the findings in mIB␣-islet cells. However, after 9 days of T2F treatment, significantly more cell death was seen in Ikk␤ ⌬␤ cell islets than in Ikk␤ F/F islets (P ϭ 0.02) (Fig. 3B) , supporting the notion that the IKK␤-NF-B pathway protects ␤ cells against TNF-␣ plus IFN-␥-mediated cytotoxicity. Similar to mIB␣-islet cells, less cell death was seen in islets of Ikk␤ ⌬␤ cell mice after I5F treatment compared with Ikk␤ F/F islets (P ϭ 0.0003) (Fig. 3C ).
NF-B Inhibition Accelerates Development of T1D.
Because the effect of NF-B on ␤ cell viability in vitro was not large and highly dependent on the cytokine combination, which may or may not mimic the in vivo situation, we directly examined the role of ␤ cell NF-B in development of autoimmune diabetes in vivo. Development of diabetes, judged by blood glucose levels, was significantly accelerated in female RIP-mIB␣/NOD mice compared with nontransgenic female littermates (P ϭ 0.0006) (Fig. 4A) , suggesting that NF-B in ␤ cells plays a protective role during T1D. Diabetes in male RIP-mIB␣/NOD mice also appeared to be accelerated relative to nontransgenic male littermates, however, the acceleration was statistically insignificant based on logrank test (P Ͼ 0.05). Nonetheless, the incidence of diabetes at 25 wk of age was significantly higher in transgenic male mice than in nontransgenic male littermates (26.7% vs. 3.3%; P ϭ 0.01) (Fig. 4B ). Significantly accelerated diabetes was also noted in female mice of a second RIP-mIB␣/NOD mouse line (Fig. 4C) . Consistent with accelerated diabetes, the number of TUNELpositive ␤ cells/islet was significantly increased in 8-wk-old female RIP-mIB␣/NOD mice compared with age-matched nontransgenic female littermates (P ϭ 0.02) (Fig. 4D) . The insulitis score was not decreased in 8-wk-old female RIP-mIB␣/NOD mice compared with nontransgenic littermates. In fact, it was slightly increased but the difference was statistically insignificant (0.850 Ϯ 0.219, n ϭ 7 vs. 0.620 Ϯ 0.189, n ϭ 7; P Ͼ 0.1), suggesting that NF-B in ␤ cells is not essential for inflammation and playing an important antiapoptotic role. Immunohistochemistry showed that CD4 ϩ or CD8 ϩ T cells, B220 ϩ B cells, and Mac-1 ϩ macrophages infiltrated pancreatic islets of female and male RIP-mIB␣/NOD mice (SI Fig. 8 ), which was similar to the findings in nontransgenic NOD mice.
Next, we studied whether the acceleration of diabetes observed in RIP-mIB␣/NOD mice could be due to overexpression of mIB␣ in ␤ cells itself. Diabetes never was observed in RIP-mIB␣/ C57BL/6 (n ϭ 55) or RIP-mIB␣/NOD-SCID mice (n ϭ 15) up to 42 wk of age, suggesting that accelerated diabetes in RIP-mIB␣/ NOD mice is not due to NF-B inhibition alone but requires autoimmune destruction of ␤ cells. Additionally, glucose tolerance test showed no significant difference in plasma glucose or serum insulin levels between RIP-mIB␣/C57BL/6 and nontransgenic C57BL/6 mice (P Ͼ 0.1) (SI Fig. 9 A and B) , suggesting that mIB␣ expression alone does not lead to diabetes. Ikk␤ ⌬␤ cell mice also did not show any apparent abnormalities in islet morphology (data not shown), glucose tolerance, or insulin levels (SI Fig. 9 C and D) .
Role of TNF-␣ in the Accelerated Diabetes of RIP-mIB␣/NOD Mice.
The in vitro results suggested that accelerated development of diabetes in RIP-mIB␣/NOD mice may be due to a dominant role of TNF-␣ in ␤ cell destruction in vivo. To examine this possibility, we investigated the effect of anti-TNF-␣ therapy on development of diabetes in RIP-mIB␣/NOD mice. When 2 ϫ 10 7 splenocytes from diabetic NOD mice were transferred to irradiated RIPmIB␣/NOD mice, diabetes developed within 8 wk after adoptive transfer. Administration of a neutralizing TNF-␣ Ab decreased the incidence of diabetes in RIP-mIB␣/NOD mice after adoptive transfer from 66.7% to 50.1% (Fig. 5A) . This difference, however, was statistically insignificant (P Ͼ 0.1), suggesting the involvement of additional death effectors. Furthermore, the incidence of diabetes after transfer of splenocytes from diabetic NOD mice was not significantly increased in RIP-mIB␣/NOD mice relative to nontransgenic recipients (P Ͼ 0.1) (Fig. 5B) . To further examine the role of TNF-␣ in accelerated diabetes of RIP-mIB␣/NOD mice without confounding effects, we adoptively transferred purified CD4 ϩ T cells from diabetic BDC2.5-SCID mice to irradiated RIP-mIB␣/NOD recipients. BDC2.5-SCID mice carry the rearranged TCR-␣ and -␤ genes of a diabetogenic CD4 ϩ T cell clone on a NOD-SCID background and develop accelerated diabetes (1). Transfer of 2 ϫ 10 6 BDC2.5 CD4 ϩ T cells rapidly induced diabetes in RIP-mIB␣/NOD mice. In this case, injection of anti-TNF-␣ almost completely abrogated the development of diabetes (P ϭ 0.0001) (Fig. 5C) , suggesting that CD4 ϩ T cells use TNF-␣ as a critical death effector in RIP-mIB␣/NOD mice. Consistently, the number of TUNEL-positive ␤ cells 3 wk after transfer of BDC2.5 CD4 ϩ T cells was decreased significantly by anti-TNF-␣ treatment (P ϭ 0.02) (Fig. 5C Inset) . We then compared incidence of diabetes after transfer of CD4 ϩ T cells between RIP-mIB␣/NOD mice and nontransgenic littermates. In these experiments, we transferred a smaller number of BDC2.5 CD4 ϩ T cells because the incidence of diabetes after transfer of 2 ϫ 10 6 BDC2.5 CD4 ϩ T cells was 100% even in nontransgenic mice. After a transfer of 5 ϫ 10 5 BDC2.5 CD4 ϩ T cells, disease development was accelerated significantly in RIP-mIB␣/NOD mice compared with nontransgenic littermates (P ϭ 0.03) (Fig. 5D) . Hence, NF-B activation within ␤ cells plays an important protective role against CD4 ϩ T cell-mediated killing through TNF-␣-dependent mechanism.
Targets for NF-B in Islet Cells. Next, we examined the effect of NF-B inhibition on expression of antiapoptotic genes in ␤ cells. RT-PCR analysis showed that expression of the caspase inhibitors, XIAP and c-FLIP, was induced after TNF-␣ treatment of pancreatic islets from nontransgenic mice when cultured in 0.2% FCS (Fig.  6A) , but not when cultured in 10% FCS (data not shown). Importantly, induction of XIAP and c-FLIP mRNAs by TNF-␣ was abrogated in mIB␣-islet cells, suggesting a requirement for NF-B (Fig. 6A) . Under the same conditions, expression of two other mRNAs coding for the apoptotic inhibitors cIAP1 and TRAF2 was constitutive and weakly elevated after TNF-␣ treatment of nontransgenic islets. Nonetheless, expression of both of these NF-B target genes was abolished in mIB␣-islets (Fig. 6A) .
Because the proapoptotic effect of mIB␣ was most significant when cells were subjected to T2F treatment, we examined the effect of IFN-␥ on XIAP and c-FLIP expression. IFN-␥ did not affect XIAP mRNA induction by 2 ng/ml TNF-␣ (Fig. 6B) . However, IFN-␥ inhibited induction of XIAP and c-FLIP proteins by TNF-␣ in nontransgenic islet cells (Fig. 6C) . This may be due to the well established inhibition of mRNA translation by IFN-␥ (36), rather than XIAP or c-FLIP cleavage by activated caspases because the cells in these experiments were pretreated with the pancaspase inhibitor, zVAD-fmk, before cytokine treatment. In mIB␣-islet cells, induction of XIAP and c-FLIP proteins by TNF-␣ was inhibited and further lowered by IFN-␥ treatment (Fig. 6C) . Hence, mIB␣ and IFN-␥ have additive inhibitory effects on XIAP expression. These findings may explain the significantly increased death of mIB␣-islet cells by T2F as compared with treatment with TNF-␣ alone.
Discussion
Despite a proapoptotic function of NF-B in ␤ cells incubated with IL-1␤ plus IFN-␥, our results reveal a dominant antiapoptotic function for NF-B in ␤ cells of NOD mice that develop autoimmune T1D. This antiapoptotic effect of NF-B was seen in ␤ cells treated in vitro with TNF-␣ plus IFN-␥, a finding consistent with previous reports that TNF-␣ plus IFN-␥ combination is an important death effector in T1D (12, 33) . Similar findings were observed by using ␤ cells from Ikk␤ ⌬␤ cell mice, indicating that the IKK␤-IB␣-NF-B pathway in ␤ cells plays an antiapoptotic role, inhibiting the cytotoxic effect of TNF-␣ or TNF-␣ plus IFN-␥. The requirement of a prolonged cytokine treatment to induce islet cell death suggests that the death response of primary ␤ cells differs from that of transformed insulinoma cells (29) and most other cell types. A requirement for a prolonged incubation time to induce ␤ cell death also was seen in the case of islet amyloid polypeptide, high concentrations of glucose, or other cytokines (37) (38) (39) . The effect of mIB␣ on islet cell death by TNF-␣ plus IFN-␥ was relatively small compared with its dramatic effect on diabetes in vivo. We have observed a much stronger effect of mIB␣ on TNF-␣-induced apoptosis of murine insulinoma cells (29) . Thus, both the small effect of mIB␣ and the requirement for a long incubation period to induce cytokine-mediated cell death appear to be unique to primary islet cells. Although the difference in cytokine (T2F)-mediated cell death was relatively small between transgenic and nontransgenic islets, it was statistically significant in more than four independent experiments despite large interassay variance. If acting cumulatively over several months during the course of T1D in NOD mice, such small differences in rates of cell death may still exert large effects on the incidence of diabetes.
Our results showing increased susceptibility of NF-B-deficient islet cells to TNF-␣-or TNF-␣ plus IFN-␥-induced cell death are consistent with the well established antiapoptotic function of NF-B (22, 40, 41) . However, many previous reports employing primary ␤ cells or insulinoma cells (17-19, 21, 42, 43) failed to detect such a function for NF-B. The underlying cause for this discrepancy is not entirely clear but could be due to differences in culture condition or cytokine treatment (12) (13) (14) (15) . Indeed, most studies that found a proapoptotic function for NF-B used IL-1 or chemical toxins rather than TNF-␣ plus IFN-␥ to elicit islet cell death (17, 18, 20, 21, 44) . We also confirmed a proapoptotic function for NF-B by using a combination of IL-1␤ plus IFN-␥. It is entirely feasible that in the context of such stimuli, NF-B may serve a proapoptotic function through induction of iNOS or other death mediators.
Nonetheless, the dominant effect of ␤ cell NF-B seen in NOD mice was inhibition of apoptosis. RIP-mIB␣/NOD mice exhibited a statistically significant enhancement of diabetes relative to nontransgenic counterparts. Furthermore, using the NOD model, we obtained evidence that an important death mediator contributed by diabetogenic CD4 ϩ T cells is TNF-␣. Neutralization of TNF-␣ blocked disease development after transfer of diabetogenic CD4 ϩ T cells into RIP-mIB␣/NOD mice. Consistent with our results, a recent paper (45) showed that diabetogenic CD4 ϩ T cells produce TNF-␣ and IFN-␥, which are highly representative of cytokines in natural T1D. Furthermore, targeted disruption of IL-1 receptor (46), caspase-1, which converts pro-IL-1␤ to active IL-1␤ (47) or iNOS (J. Fenyk-Melody and J. S. Mudgett, personal communication) have little protective effects on the development of T1D in NOD mice. These results suggest that IL-1␤ and NO do not play major pathogenic role in this model of T1D. In contrast, NOD mice deficient in TNF receptor 1 do not develop spontaneous diabetes, and TNF receptor 1-deficient ␤ cells are resistant to killing by CD4 ϩ T cells (10, 11) .
It also was reported that inhibition of ␤ cell NF-B by using a different mIB␣ transgene resulted in impaired glucose tolerance and insulin production (48) . A recent paper (49) also reported impaired glucose tolerance upon Cre expression in pancreatic ␤ cells. However, we found that NF-B inhibition or Cre-mediated deletion of Ikk␤ alone did not result in impaired glucose tolerance or diabetes. More recently, however, NF-B blockade by mIB␣ transgene similar to the one used in our study was found to inhibit development of diabetes by multiple low-dose streptozotocin (50) . However, the mechanism accounting for development of diabetes by multiple low-dose streptozotocin is not clear and probably different from that of spontaneous T1D in NOD mice, which provides a better mimic of human T1D. Nonetheless, in agreement with that study, we observed significantly decreased incidence of diabetes after a single low-dose streptozotocin treatment (100 mg/kg) in both RIP-mIB␣/C57BL/6 mice and Ikk␤ ⌬␤ cell mice compared with their respective nontransgenic littermates (SI Fig.  10 ). These results suggest that like IL-1␤ plus IFN-␥, induction of ␤ cell death by low-dose streptozotocin also depends on NF-B activation.
The antiapoptotic function of NF-B in ␤ cells may be mediated by XIAP and c-FLIP, whose transcriptional induction by TNF-␣ was suppressed by mIB␣. Moreover, IFN-␥, which potentiates the cytotoxic response to TNF-␣, further inhibited XIAP and c-FLIP protein expression, thus providing a possible explanation for the important auxiliary role of IFN-␥ in ␤ cell destruction. Although XIAP was shown to have antiapoptotic function in islet cells (51) , c-FLIP is a well established inhibitor of TNF␣-induced cell death (52) .
In summary, these results demonstrate a protective role for NF-B in pancreatic ␤ cells, preventing their destruction by TNF-␣-mediated cytotoxicity during T1D. These findings, we believe, also resolve a previous controversy regarding the role of NF-B in ␤ cells and support TNF-␣ as a dominant mediator of pancreatic ␤ cell death in vivo. If extendable to human disease, our results suggest that NF-B inhibitors should not be used for prevention or treatment of T1D unless specifically directed to inflammatory cells. Furthermore, it needs to be examined whether potent and global inhibition of NF-B also may be damaging in T2D by accelerating ␤ cell loss despite the enhancement of insulin sensitivity (30, 31) . Nonetheless, the effect of IKK-NF-B activation on ␤ cell function or viability may not be the same in T1D and T2D because it depends highly on the cytokine milieu to which the ␤ cell is exposed.
Materials and Methods
RIP-mIB␣ Mice. Mutated human IB␣ cDNA sequence lacking the IKK phosphorylation sites and ubiquitination sites (mIB␣) was inserted into a ␤ cell-specific expression vector containing the rat insulin promoter (RIP-mIB␣). A fragment spanning the RIPmIB␣ cassette was injected into fertilized eggs of NOD mice to generate RIP-mIB␣/NOD mice. Mice were considered diabetic if nonfasting blood glucose level was Ͼ300 mg/dl. Immunohistochemistry. After deparaffinization, sections were stained by using insulin (DAKO, Carpinteria, CA), glucagon (Chemicon, Temecula, CA), and somatostatin Ab (DAKO) to identify ␤ cells, ␣ cells, and ␦ cells, respectively (2).
Isolation of Mouse Pancreatic Islets. Pancreatic islets were isolated by intraductal collagenase injection and Ficoll gradient separation as described (12) . After hand picking and trypsin-EDTA treatment, single islet cells were cultured in RPMI medium 1640-10% FCS.
Immunoblot Analysis. Immunoblotting was conducted by using IB␣ (Santa Cruz Biotechnology, Santa Cruz, CA), iNOS (Pharmingen, La Jolla, CA), XIAP (MBL, Nagoya, Japan), or c-FLIP (Stressgen, Ann Arbor, MI) Abs as described (12) . For XIAP and c-FLIP analysis, single islet cells were preincubated in RPMI medium 1640-0.2% FCS for 24 h and treated with TNF-␣ or TNF-␣ plus IFN-␥ for 48 h after pretreatment with 50 M zVAD-fmk (Enzyme Systems. Livermore, CA) for 30 min to inhibit the possible caspasemediated degradation.
Confocal Microscopy. Primary single-islet cells on chamber slides were fixed in 4% paraformaldehyde. Cells were sequentially incubated with RelA/p65 Ab (Santa Cruz Biotechnology), biotinylated anti-mouse IgG, and streptavidin-TRITC. Cells were incubated further with insulin Ab and then with FITC-anti-guinea pig IgG and 10 g/ml Hoechst33342. Stained cells were observed by using a confocal microscope (Bio-Rad, Hercules, CA), and the number of cells showing nuclear translocation of RelA/p65 was counted by a single observer, blinded to the islet genotype.
Cell Death Assay. Single-islet cells (2 ϫ 10 4 per well) were treated with cytokines. To measure cell viability and death, MTT assay and Hoechst33342 staining, respectively, were used (12) . To detect ␤ cell death, cells were incubated with insulin Ab and then with FITC-anti-guinea pig IgG together with Hoechst33342 for fluorescent microscopy. TUNEL staining combined with immunohistochemistry was conducted to identify apoptotic ␤ cells in pancreatic sections (2) . To quantitate apoptotic ␤ cells, Ͼ50 islets from more than three parallel sections of different cut levels were analyzed per mouse by a single observer, blinded to the mouse genotype.
For insulitis scoring, Ͼ40 islets from more than three parallel sections per mouse were analyzed. The degree of insulitis was classified as: 0, no insulitis; 1, periinsulitis with minimal lymphocytic infiltration in islets; 2, invasive insulitis with islet destruction Յ50%; and 3, islet destruction Ͼ50% (12).
Adoptive Transfer. Splenocytes from diabetic NOD mice or from BDC2.5-SCID mice (kindly provided by C. Benoist and D. Mathis, Harvard University, Boston, MA) were infused into the tail vein of sublethally irradiated 6-to 8-wk-old NOD or RIP-mIB␣/NOD mice of the same sex (9) . TNF-␣ Ab (MP6-XT22.11) was prepared as described (12) , and 0.5-mg doses were injected i.p. 30 min before adoptive transfer and three times per week thereafter. Control recipients were treated with PBS or control IgG.
RT-PCR. PCR employing total RNA extracted from primary islet cells and specific primer sets was carried out at 58°C annealing temperature for 30 cycles.
Statistical Analysis. Incidence of diabetes was plotted according to the Kaplan-Meier method and compared by using the logrank test. Diabetes incidence at specific time points and fractions of apoptotic cells were compared by using the binominal test. Student's t test was used to compare cell death, insulitis score, and apoptotic ␤ cell number. P Ͻ 0.05 determined by two-tailed test was considered as statistically significant.
